###begin article-title 0
Overexpression of Transforming Growth Factor-beta1 in the Valvular Fibrosis of Chronic Rheumatic Heart Disease
###end article-title 0
###begin p 1
###xml 535 536 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 729 730 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 758 759 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 800 801 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 830 831 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 859 860 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1008 1009 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For the purpose of determining the pathogenic role of transforming growth factor-beta1 (TGF-beta1) in the mechanism of chronic rheumatic heart disease, we evaluated the expression of TGF-beta1, proliferation of myofibroblasts, and changes in extracellular matrix components including collagen and proteoglycan in 30 rheumatic mitral valves and in 15 control valves. High TGF-beta1 expression was identified in 21 cases (70%) of rheumatic mitral valves, whereas only 3 cases (20%) of the control group showed high TGF-beta1 expression (p<0.001). Additionally, increased proliferation of myofibroblasts was observed in the rheumatic valves. High TGF-beta1 expression positively correlated with the proliferation of myofibroblasts (p=0.004), valvular fibrosis (p<0.001), inflammatory cell infiltration (p=0.004), neovascularization (p=0.007), and calcification (p<0.001) in the valvular leaflets. The ratio of proteoglycan to collagen deposition inversely correlated with TGF-beta1 expression in mitral valves (p=0.040). In conclusion, an ongoing inflammatory process, the expression of TGF-beta1, and proliferation of myofibroblasts within the valves have a potential role in the valvular fibrosis, calcification, and changes in the extracellular matrix that lead to the scarring sequelae of rheumatic heart disease.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 242 263 <span type="species:ncbi:36470">group A streptococcus</span>
###xml 347 352 <span type="species:ncbi:9606">human</span>
Valvular involvement in heart disease results in stenosis, insufficiency, or both, and the most common cause of mitral stenosis is chronic rheumatic heart disease (1, 2). Rheumatic fever (RF) is the consequence of a pharyngeal infection with group A streptococcus in a susceptible host, leading to autoimmune disease induced by antigen mimicry of human cardiac myosin with the streptococcal glycoprotein (3). While most disease manifestations are transient and leave no residua, rheumatic carditis can lead to chronic rheumatic heart disease (CRHD), which is characterized by fibrotic valvular deformity and can produce permanent and severe cardiac dysfunction even decades later (1).
###end p 3
###begin p 4
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 524 525 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 526 527 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 760 761 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1069 1070 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1071 1073 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">patients</span>
The current hypothesis of CRHD is that fibrotic valvular deformity evolves through organization of acute inflammation induced by RF, with subsequent thickening and retraction of valvular leaflets, and with secondary damage resulting from turbulent flow induced by valvular dysfunction (1, 4). There are some evidences that CRHD is associated with ongoing inflammation of valvular leaflets. The plasma concentrations of TNF-alpha and high sensitive C-reactive protein (CRP) are significantly higher in CRHD than in controls (5-7). It has been shown that lymphocytes obtained from CRHD patients exhibit T helper 2 (Th2) type cytokine response whereas those from RF patients show T helper 1 (Th1) cytokine profile in cell culture with streptococcal superantigen (8). The Th2 immune response is known to promote fibrotic process by activating fibroblast proliferation, myofibroblast differentiation, extracellular matrix deposition, and transforming growth factor-beta 1 (TGF-beta1) production, whereas Th1 type cytokines such as interferon-gamma suppress these processes (9-11).
###end p 4
###begin p 5
###xml 90 92 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 522 524 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 526 528 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 611 613 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 614 616 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 680 682 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 733 735 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 930 932 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1082 1084 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
TGF-beta1 plays a critical role in matrix remodeling and in enhancing collagen synthesis (12). Upon tissue injury, inflammation occurs and many cytokines are secreted and TGF-beta1 is released, promotes myofibroblast differentiation, and stimulates fibroblasts and other reparative cells to proliferate and to synthesize extracellular matrix components. Under normal conditions this leads to provisional repair; however, with repeated injury, the increase in TGF-beta1 production is sustained, leading to tissue fibrosis (13, 14). Recent studies have investigated TGF-beta1 expression in diseased heart valves (15-17). Serotonin, which is associated with carcinoid heart disease (18), has been demonstrated to up-regulate TGF-beta1 (15). Other reports indicate that TGF-beta1 is present within calcific aortic stenosis cusps and that it mediates the calcification of aortic valve interstitial cells in cell culture via apoptosis (16). Additionally, in CRHD, the possibility that TGF-beta1 gene polymorphism might play a role in determining the susceptibility to CRHD was suggested (17).
###end p 5
###begin p 6
In this study, we investigated the expression of TGF-beta1 and changes in extracellular matrix components in mitral valves affected by CRHD in order to determine the role of TGF-beta1 in the delayed valvular fibrosis and deformity caused by CRHD.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and specimens
###end title 8
###begin p 9
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 442 450 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
###xml 696 704 <span type="species:ncbi:9606">patients</span>
Rheumatic mitral valves were obtained from pathology slides of 30 patients with CRHD who underwent valve removal and prosthetic valve replacement surgery carried out from 2002 to 2003 in Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. These patients showed typical echocardiographic and gross findings of CRHD. Cases complicated with infectious endocarditis or collagen vascular disease were excluded. The age of the patients ranged from 25 to 74 yr (mean, 49.7 yr old), with 13 males and 17 females. The number of patients having mitral stenosis was 15, those with mitral regurgitation were 5, and those with both mitral stenosis and regurgitation were 10. Twenty-three patients demonstrated multiple valve involvement.
###end p 9
###begin p 10
###xml 252 260 <span type="species:ncbi:9606">patients</span>
Normal heart valves were obtained from autopsies (14 cases) and from the removed heart of a transplantation recipient (1 case), with the diagnosis of dilated cardiomyopathy with Marfan syndrome but without definite valvular abnormality. The age of the patients ranged from 12 to 73 yr (mean, 39.9 yr), with 12 males and 3 females. The hearts obtained at autopsy were devoid of any abnormal findings except mild thickening of valvular leaflets in three cases. The causes of death were not heart-related. Specimens were fixed in 10% buffered formalin and embedded in paraffin. Serial sections were stained with hematoxylin and eosin for general morphology.
###end p 10
###begin title 11
Pathologic examination
###end title 11
###begin p 12
Pathologic examination of sections was carried out blinded to the clinical diagnosis. The status of valvular architecture was evaluated in comparison to the well established histology offered by the normal valves. The extent of fibrosis, the degree of inflammatory infiltrates and neovascularization, and the presence of patchy necrosis, calcification, and thrombus attachment in valvular leaflets were examined. The extent of fibrosis was semiquantitatively graded as follows: no change (-); mild fibrosis without architectural distortion: (1+); moderate fibrosis with architectural distortion: (2+); severe fibrosis obliterating the valvular architecture (3+). The inflammatory infiltrates was graded as follows: no inflammation: (-); scanty amount of inflammatory cell infiltration in the stroma: (1+); and moderate inflammatory cell infiltration: (2+). The cases showing severe inflammation in the stroma and endocardial surface of the valvular leaflets were excluded in this study. The degree of neovascularization was graded as: no change: (-); presence of several thin-walled vessels: (1+); presence of a few muscularized vessels: (2+); and presence of aggregates of muscularized and ectatic thin-walled vessels: (3+). Myxoid degeneration of valvular leaflets was scored as follows: <5%: (-), 6-25%: (1+), 25-50%: (2+), and >50% of areas showing myxoid degeneration in any low-power field: (3+).
###end p 12
###begin title 13
Characterization of extracellular matrix deposition in valvular leaflets
###end title 13
###begin p 14
Histochemical evaluation was performed for connective tissue elements with Movat pentachrome stain, which differentially stains collagen, elastin, and proteoglycans, to evaluate the architectural distortion, alcian blue (pH 2.0) to stain for proteoglycans, and Sirius red to stain for collagen, according to previously described methods. The slides stained with Movat pentachrome and alcian blue were examined under light microscope, and the sections stained with Sirius red were observed under polarizing microscope. Analysis of the extent of alcian blue and Sirius red staining was performed with a personal computer-based quantitative 24-bit (16.2 million unique combinations) color image analysis system (KS400, Ver. 2.0, Zeiss, Germany). The slides were scanned, negative background (black) was chosen for the threshold and the positive area was calculated by subtraction. The same threshold was applied to all specimens. The percentage of the total area with positive color for each section was recorded.
###end p 14
###begin title 15
Immunohistochemistry
###end title 15
###begin p 16
###xml 589 600 <span type="species:ncbi:3704">horseradish</span>
Paraffin-embedded tissues were sectioned in 4-microm slices. Sections were preincubated with 3% hydrogen peroxide, and antibodies against TGF-beta1 (Serotec, Oxford, U.K.), vimentin (M7020, Dako Cytomation, Glostrup, Denmark), alpha-smooth muscle actin (SMA) (Dako Cytomation), CD3 (Novocastra, Newcastle, U.K.), CD20 (BD Pharmingen, San Diego, CA, U.S.A.), and CD68 (Dako Cytomation) were applied and incubated for 60 min at room temperature. Sections were incubated with biotinylated secondary antibody (Cap-plus kit, Zymed, San Francisco, CA, U.S.A.) for 30 min and then incubated with horseradish peroxidase-labelled streptavidin solution (Cap-plus kit, Zymed) for 30 min. Slides were rinsed in phosphate-buffered saline (pH 7.4) after each incubation step. Peroxidase activity was revealed by diaminobenzidine. Slides were counterstained with hematoxylin and mounted. Positive reaction for TGF-beta1 was semi-quantitatively evaluated according to the extent of positive stromal area in any lowpower field (X40) as follows: <5%: negative, 5 to 25%: low, and >25%: high expression. The proliferation of myofibroblasts was graded according to the extent of SMA-positive myofibroblasts among valvular interstitial cells as: <5%: negative, 5 to 25%: low, and >25%: high degree.
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 408 409 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis was performed using the PC-SPSS program (Ver 11.0, IL, U.S.A.). The data were calculated as mean+/-standard deviation when availabel. Fisher's exact test was used to analyze the data obtained from immunohistochemical findings, and the non-parametric Mann-Whitney U test was employed to evaluate the association of TGF-beta1 expression with the deposition of proteoglycan and collagen. A p value less than 0.05 was considered to be statistically significant.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
Histologic findings of rheumatic mitral valves
###end title 20
###begin p 21
###xml 89 96 89 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
Histologic findings of the rheumatic mitral valves and control valves were summarized in Table 1. All control valvular leaflets showed architectural preservation of three layers including spongiosa, fibrosa, and ventricularis (Fig. 1A). Mild fibrosis was seen in three of them, mild to moderate myxoid degeneration in thirteen, and scanty lymphocytic infiltrates in two. Several CD68-positive histiocytes were present in the stroma of valve leaflets. Neovascularization, calcification, thrombus attachment, and necrosis of the leaflets were not observed.
###end p 21
###begin p 22
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 403 410 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2B</xref>
By contrast, in all rheumatic mitral valves, valvular architectures were markedly distorted due to moderate-to-severe fibrosis (Fig. 2A). Neovascularization was seen in the central portion of the valvular leaflet in 26 cases. Six cases showed thin-walled small vascular structures and others contained thick muscularized vessels. Inflammatory cells infiltrated into the perivascular stroma in 15 cases (Fig. 2B) and were predominantly composed of CD3+ T lymphocytes. Thrombi were attached on the valvular leaflets in 11 cases, calcification was noted in 18 cases, and focal necrosis was found in the fibrotic stroma in 11 cases. Myxoid degeneration of valvular stroma was seen in 18 cases.
###end p 22
###begin p 23
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
In those cases showing extensive stromal fibrosis in the vavluar leaflets, more pronounced neovascularization (p<0.001), increased inflammatory infiltrates (p=0.033), calcification (p<0.001), stromal necrosis (p=0.004), and thrombus attachment (p=0.009) were observed. Myxoid degeneration was seen in areas where fibrosis or calcification was not intense.
###end p 23
###begin title 24
Immunohistochemical expression of TGF-beta1 and SMA in control and rheumatic mitral valves
###end title 24
###begin p 25
###xml 167 168 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 177 184 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 284 291 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 506 513 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2C</xref>
###xml 584 585 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 626 627 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 656 657 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 684 685 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 780 781 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
In CRHD, 21 cases of rheumatic valves (70%) showed high TGF-beta1 expression, whereas only three cases of control valves (20%) demonstrated high TGF-beta1 expression (p<0.001) (Table 2). Control valves exhibited TGF-beta1 positivity on the subendothelial stroma of valvular leaflets (Fig. 1B). On the other hand, in CRHD, TGF-beta1 was expressed in the endothelial cells and smooth muscle cells of the blood vessels (13 cases), the interstitial cells and perivascular stroma (3 cases), or both (14 cases) (Fig. 2C). High TGF-beta1 expression correlated with severe valvular fibrosis (p<0.001), inflammatory cell infiltration (p=0.004), neovascularization (p=0.007) and calcification (p<0.001), but no correlation was observed between TGF-beta1 expression and myxoid degeneration (p=0.173).
###end p 25
###begin p 26
###xml 127 134 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 239 240 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 249 256 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 293 294 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 435 442 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2D</xref>
The number of SMA-positive myofibroblasts was significantly increased in valvular leaflets of CRHD compared to control valves (Table 3), and the proliferation of SMA-positive myofibroblasts positively correlated with TGF-beta1 expression (p=0.004) (Table 4) and fibrosis of valvular leaflets (p<0.001). SMA-positive myofibroblasts were usually seen in the areas showing increased collagen deposition, and in the subendocardial stroma (Fig. 2D).
###end p 26
###begin title 27
Deposition of collagen and proteoglycan in control and rheumatic mitral valves
###end title 27
###begin p 28
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 661 668 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3A</xref>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 866 873 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3B</xref>
###xml 1018 1019 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1129 1130 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1271 1272 1265 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1280 1287 1274 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3C</xref>
Extracellular matrix deposition of proteoglycan and collagen was markedly different in the CRHD and control groups. In control valves, the proteoglycan was present in the spongiosa and collagen was found in the fibrosa. Whereas, in CRHD, proteoglycan was deposited in the perivascular stroma or in areas showing myxoid degeneration, and the collagen was in the stroma showing dense fibrosis or myofibroblastic proliferation. The proportion of alcian blue-positive areas quantitatively calculated by image analyzer occupied a mean of 3.75% (range 0-23.5%) of valvular matrix in CRHD, compared to the mean of 13.2% (range 0-41.9%) in the control group (p=0.014) (Fig. 3A). The proportion of Sirius redpositive areas, which represent type I and III collagen deposition, averaged 23% (range 8.1-51.4%) in CRHD and 11.2% (range 5.9-22.0%) in the control group (p<0.001) (Fig. 3B). Additionally, the ratio of proteoglycan to collagen deposition was lower in the rheumatic mitral valve group than in the control valve group (p=0.001). The proportion of collagen and proteoglycan deposition was not associated with TGF-beta1 expression (p=0.34 and 0.087), but the ratio of proteoglycan to collagen deposition was lower in the TGF-beta1 positive group than in the negative group (p=0.04) (Fig. 3C).
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 419 421 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 453 455 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 516 518 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 752 754 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 629 637 <span type="species:ncbi:9606">patients</span>
CRHD, the most significant complication of RF, demonstrates severe fibrosis and distortion of valvular leaflets (1, 3). The factors leading to continued fibrosis and subsequent valvular disease remain incompletely defined. There are considerable evidences to indicate that TGF-beta1 overproduction plays some role in fibrosis and dysfunction in heart valves. TGF-beta1 expression is increased in carcinoid valve cusps (15), calcific aortic valve cusps (16), and prolapsed valves in a mouse model of Marfan syndrome (19). In cases of CRHD, TGF-beta1 polymorphisms may predispose to valvular disease. Chou et al. demonstrated that patients with CRHD have a lower frequency of the TGF-beta1 C509T CC genotype and a higher frequency of the T869C T allele (17). They proposed the possibility that TGF-beta1 gene polymorphisms might play a role in determining susceptibility to CRHD. However, there has been no study showing localized overproduction of TGF-beta1 in valvular leaflets of CRHD. Our study has demonstrated high TGF-beta1 expression in valvular leaflets of CRHD and might support the hypothesis that TGF-beta1 overproduction would play a role in the valvular fibrosis of CRHD.
###end p 30
###begin p 31
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 649 650 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 652 653 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 655 656 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 658 660 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 707 708 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1057 1058 1050 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1059 1061 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1082 1084 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1540 1541 1533 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1543 1545 1536 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1707 1708 1700 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
###xml 1205 1213 <span type="species:ncbi:9606">patients</span>
###xml 1326 1334 <span type="species:ncbi:9606">patients</span>
###xml 1408 1416 <span type="species:ncbi:9606">patients</span>
###xml 1473 1481 <span type="species:ncbi:9606">patients</span>
It may be difficult to appreciate that, in valvular leaflets of CRHD, fibrosis and remodeling is going on even several decades after initial attack. There are some studies demonstrating persistent inflammation in valvular leaflets of CRHD (4, 20, 21). Lymphocytic infiltrations have been identified in valves removed 10-20 yr after initial attacks of RF, and the predominant cellular infiltrate was T lymphocytes (4). Prolonged persistence of group A streptococcal carbohydrate antibody was demonstrated in CRHD even decades later (20). Additionally, the plasma concentrations of TNF-alpha and highly sensitive CRP are significantly higher in CRHD (5, 6, 7, 21). According to the study by Bhatnagar et al. (8), lymphocytes derived from CRHD patients exhibit the Th2 type cytokine response whereas those from RF patients show the Th1 cytokine profile with response to the streptococcal superantigen. The Th2 immune response is associated with fibrotic process including TGF-beta1 secretion, whereas Th1 type cytokines suppresses diverse fibrotic activities (9-11). Guilherme et al. (22) demonstrated that CD4+ T cells derived from heart lesions predominantly secrete Th1 type cytokines in both RF and CRHD patients. The different results observed in these two studies are probably due to the different characterization of CRHD patients analysed. The study by Guilherme et al. included the early stage of CRHD patients with age range from 10 to 20 yr, whereas the age of the patients in the study by Bhatnagar et al. ranged from 22 to 54 yr (8, 22). Therefore, the cytokine profiles of early stage CRHD might be similar to that of RF. It is possible that Th2 type cytokine response seen in the advanced CRHD (8) might be induce the TGF-beta1 overexpression and the fibrotic process as well as prolonged inflammation seen in the distorted rheumatic valves. Our report confirmed the fact that ongoing inflammation mainly composed of T lymphocytes was present in the apparently resting valves of advanced CRHD, and TGF-beta1 expression correlated with the degree of inflammatory infiltrates. Additionally, TGF-beta1 expression was present predominantly in the perivascular stroma where inflammatory cells mainly infiltrated. These results support the hypothesis that a continued inflammatory process and overproduction of TGF-beta1 within the valves of the susceptible hosts would lead to the prolonged fibrosis of valvular leaflets in advanced CRHD.
###end p 31
###begin p 32
###xml 80 82 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 164 166 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 275 277 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 722 724 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 923 925 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
TGF-beta1 induces the differentiation of cardiac fibroblasts to myofibroblasts (24), which can produce up to twice as much collagen as their fibroblast precursors (25). The emergence of these cells has been closely correlated with valvular fibrosis and degenerative lesions (26). Our study demonstrated that increased proliferation of myofibroblasts was observed in the rheumatic valves without alteration of cellularity of valvular interstitial cells and that high TGF-beta1 expression was related to the proliferation of myofibroblasts and calcification of valvular leaflets. Calcific aortic stenosis cusps demonstrate higher concentrations of TGF-beta1 within the extracellular matrix compared with noncalcified cusps (16). When cultured interstitial cells are exposed to TGF-beta1 for a long period of time, aggregates of cells evolve into nodules that become apoptotic, express alkaline phosphatase, and then calcify (16). Therefore, increased TGF-beta1 expression in rheumatic heart valves may induce the differentiation of valvular interstitial cells to the myofibroblasts and the overproduction of extracellular matrix, resulting in progressive fibrosis and valvular distortion, and rolonged exposure to TGF-beta1 probably induces calcification of valvular leaflets seen in CRHD.
###end p 32
###begin p 33
###xml 102 104 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 258 260 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 370 372 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
TGF-beta1 is also known to play a critical role in matrix remodeling by enhancing collagen synthesis (12). The normal heart valve is composed of collagen, proteoglycan and elastin, and approximately 85% of the total collagen in the heart is type I collagen (27). In rheumatic valves, the total amounts of collagen, proteoglycan, and elastin are significantly increased (27). Our result demonstrated that the proportion of collagen deposition was increased, and proteoglycan deposition was decreased in rheumatic valvular leaflets compared to control valves, but that it did not correlate with TGF-beta1 overexpression. Because only the percentage of collagen and proteoglycan deposited areas in the valvular leaflets was evaluated and the total amount of collagen was not calculated, we were unable to investigate the accurate relationship of collagen deposition to TGF-beta1 expression. However, the ratio of proteoglycan to collagen deposited areas was lower in the TGF-beta1 positive group than in the negative group. Therefore TGF-beta1 expression might be related to the conversion of extracellular matrix from proteoglycan to collagen rather than to the percentage of collagen or that of proteoglycan.
###end p 33
###begin p 34
###xml 270 272 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
There are a number of efforts that have aimed to reduce fibrosis in cardiovascular disease, such as post-ischemic fibrosis, and dilated and hypertrophic cardiomyopathies, and targeting the TGF-beta1 may be effective in attenuating fibrosis and hypertrophy in the heart (26). Our study indicated that TGF-beta1 may play some role in valvular fibrosis and deformity in CRHD, and therefore, TGF-beta1 might be an appropriate target for prevention of subsequent valvular dysfunction in patients having suffered from RF.
###end p 34
###begin p 35
In conclusion, TGF-beta1 expression is increased in rheumatic mitral valves, and higher TGF-beta1 expression is associated with valvular fibrosis, inflammatory cell infiltration, differentiation of valvular fibroblasts to myofibroblasts, calcification, and changes in the extracellular matrix in the valves of CRHD. These results support the hypothesis that TGF-beta1 expression might play some role in the prolonged fibrosis and severe valvular deformity typical of CRHD.
###end p 35
###begin title 36
ACKNOWLEDGEMENTS
###end title 36
###begin p 37
We thank Kyung Moo Yang, Pathologist in National Institute of Scientific Investigation for his contribution of collection of control valves, and members of the Department of Pathology, Inha University Hospital and Yonsei University College of Medicine for their supports. We express our sorrow over the death of Dr. Dong Hwan Shin, one of the coauthors of this article.
###end p 37
###begin article-title 38
The heart
###end article-title 38
###begin article-title 39
Cardiovascular system
###end article-title 39
###begin article-title 40
Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease
###end article-title 40
###begin article-title 41
Identification of mononuclear cells and T cell subsets in rheumatic valvulitis
###end article-title 41
###begin article-title 42
Balance between plasma levels of tumor necrosis factor-alpha and interleukin-10 in rheumatic mitral stenosis
###end article-title 42
###begin article-title 43
Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP)
###end article-title 43
###begin article-title 44
Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class
###end article-title 44
###begin article-title 45
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients
###end article-title 45
###begin article-title 46
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet
###end article-title 46
###begin article-title 47
Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis
###end article-title 47
###begin article-title 48
###xml 72 77 <span type="species:ncbi:9606">human</span>
Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads
###end article-title 48
###begin article-title 49
Transforming growth factor beta in tissue fibrosis
###end article-title 49
###begin article-title 50
Transforming growth factor betas and wound healing
###end article-title 50
###begin article-title 51
Mechanisms of tissue repair: from wound healing to fibrosis
###end article-title 51
###begin article-title 52
Serotonin mechanisms in heart valve disease I: Serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells
###end article-title 52
###begin article-title 53
Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis
###end article-title 53
###begin article-title 54
Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease
###end article-title 54
###begin article-title 55
Carcinoid heart disease: Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography
###end article-title 55
###begin article-title 56
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
TGFbeta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
###end article-title 56
###begin article-title 57
Effect of valvular surgery on antibody to the group A streptococcal carbohydrate
###end article-title 57
###begin article-title 58
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation
###end article-title 58
###begin article-title 59
Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions
###end article-title 59
###begin article-title 60
Transforming growth factor-beta in T-cell biology
###end article-title 60
###begin article-title 61
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease
###end article-title 61
###begin article-title 62
Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts
###end article-title 62
###begin article-title 63
Fibrosis in heart disease: understanding the role of transforming growth factor-beta1 in cardiomyopathy, valvular disease and arrhythmia
###end article-title 63
###begin article-title 64
###xml 72 77 <span type="species:ncbi:9606">human</span>
Biochemical characterization of individual normal, floppy and rheumatic human mitral valves
###end article-title 64
###begin p 65
###xml 27 51 27 51 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inha University Research</funding-source>
###xml 59 69 59 69 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INHA-31448</award-id>
This work was supported by Inha University Research Grant (INHA-31448).
###end p 65
###begin p 66
###xml 63 66 63 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 223 226 223 226 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
Histologic and immunohistochemical findings of control valves. (A) Valvular leaflets obtained from the control group showed well-preserved leaflet architecture without fibrosis or inflammatory cell infiltration (H&E, x40). (B) Immunohistochemical staining for TGF-beta1 demonstrated positivity in the subendothelial stroma of valvular leaflets (TGF-beta1, x40).
###end p 66
###begin p 67
###xml 76 79 76 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 166 169 166 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 282 285 282 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 459 462 456 459 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
Histologic and immunohistochemical findings of the rheumatic mitral valves. (A) Rheumatic mitral valves showed severe fibrosis and distorted architecture (H&E, x40). (B) A high-power view demonstrated small thin-walled vessels and perivascular lymphocytic infiltration (H&E, x200). (C) High TGF-beta1 expression was seen in the endothelial cells and smooth muscle cells of the vessels, in the perivascular interstitial cells, and stroma of the valves (x200). (D) Myofibroblasts that were positive for SMA immunostaining were present in the subendothelial densely fibrotic area (x40).
###end p 67
###begin p 68
###xml 84 87 84 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 273 276 273 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 445 448 445 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 635 636 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Proteoglycan and collagen deposition in rheumatic mitral valves and control valves. (A) The proportion of proteoglycan deposited areas was lower in rheumatic mitral valve group (RM) than in the control group (black bars represented mean values: 3.75% vs. 13.2%) (p=0.014). (B) The rheumatic mitral valve group (RM) showed extensive collagen deposition compared to the control group (black bars represented mean values: 23% vs. 11.2%) (p<0.001). (C) The ratio of proteoglycan to collagen deposited areas was lower in the TGF-beta1 positive group than in the TGF-beta1 negative group (black bars represented mean values: 0.38 vs. 0.66) (p=0.040).
###end p 68
###begin p 69
Histologic features of rheumatic mitral valves and control valves
###end p 69
###begin p 70
RMV, rheumatic mitral valve; (-), negative; (+), positive.
###end p 70
###begin p 71
Comparison of TGF-beta1 expression between rheumatic mitral valves and control group valves
###end p 71
###begin p 72
RMV, rheumatic mitral valve.
###end p 72
###begin p 73
Proliferation of SMA-positive myofibroblasts in rheumatic mitral valves and control group valves
###end p 73
###begin p 74
SMA, alpha-smooth muscle actin.
###end p 74
###begin p 75
Proliferation of SMA-positive myofibroblasts in valvular leaflets according to TGF-beta1 expression
###end p 75
###begin p 76
SMA, alpha-smooth muscle actin.
###end p 76

